day 1 agenda

Scientific Program
World Congress on Traditional, Complementary and Integrative Medicine
June 18-19 at Prague, Czech Republic  (Hybrid Event)
Day -1 (June 18, 2026)
08:30-09:20 Registrations
09:20-09:30 Moderator Speech
Keynote Forum | 09:30-11:00
11:00-11:20 | Group Photo & Refreshment Break
Technical Session I | 11:20-13:00
13:00-14:00 | Lunch Break
Technical Session II | 14:00-16:00
16:00-16:20 | Refreshment Break
Technical Session III | 16:20-18:00
Panel Discussion & End of Day-1

day 2 agenda

Scientific Program
World Congress on Traditional, Complementary and Integrative Medicine
June 18-19 at Prague, Czech Republic  (Hybrid Event)
Day -2 (June 19, 2026)
09:20-09:30 Moderator Speech
Keynote Forum | 09:30-11:00
11:00-11:20 | Refreshment Break
Technical Session I | 11:20-13:00
13:00-14:00 | Lunch Break
Technical Session II | 14:00-16:00
16:00-16:20 | Refreshment Break
Technical Session III | 16:20-18:00
Panel Discussion & Closing Ceremony

posters agenda

Virtual Scientific Program
5th International Pharma Research & Development (PN-2026)
June 18, 2026 |
Day-1 (June 18, 2026), (CET Time zone)
Paul A. Insel, 
University of California San Diego, USA
09:30-10:10 Title:-G protein-coupled receptors (GPCRs) as novel cancer targets
Carl C. Peck, 
University of California at San Francisco, USA
10:10-10:50 Title:-Bayesian Bioequivalence Analysis is Preferable to TOST
Sitting Hong,
First Affiliated Hospital of Harbin Medical University, China
10:50-11:30 Title:- Vascular protective effect of exogenous hydrogen sulfide in spontaneously hypertensive rats fed a high-fat diet
Camillo Benetti,
National University, Singapore
11:30-11:50 Title:- Novel therapeutic topical gel approach for chronic inflammation and pain management in osteo- and viral-arthritis
Samiron,
Integrated Drug Discovery, Argen Lifessciences Ltd, India
11:50-12:10 Title:- Advancing ML Models for Oral Drug PK through diverse descriptor classes: Focus on Vdss & PPB
Tong Yin, 
Institute of Geriatrics, General Hospital of Chinese PLA, China
12:10-12:30 Title:- Drug-gene interactions contribute to the prognostic outcomes in older patients with coronary artery disease
Guohui Jiang,
North Sichuan Medical College, China
12:30-12:50 Title:- Cross-disease drug discovery based on bioinformatics and virtual screening: Study of key genes in Alzheimer’s disease and ovarian cancer
Jialing Shi,
BASIS International School Wuhan, China
12:50-13:10 Title:- Large language model-guided reinforcement learning for de novo EGFR anticancer drug design
Wen-ting Dai,
 
Zhejiang University of Technology, China
13:10-13:30 Title:- Biochanin A Regulates Mitochondrial Function to Exert Its Role in the Prevention and Control of Colon Cancer
Helmut A. Greim, 
Technical University of Munich, Germany
13:30-13:50 Title:-Achievements of Emil Starkenstein, former Professor of Pharmacology at Charles University of Prague
Sofie Godfried Declercq,
Vrije Universiteit Brussel, Belgium
13:50-14:10 Title:-Traceless by design, fast by nature: an enzyme (mix) for rapid, mild and site-specific radiolabeling of proteins
Alejandro Lopez-Rincon, 
Utrecht University, Netherlands
14:10-14:30 Title:-Machine Learning Education Through Public Gene Expression Data
David E. Gloriam, 
Uppsala University, Sweden
14:30-14:50 Title:-Trends in GPCR drug discovery
Renu Chaudhary, 
Italian
Society of Hospital Pharmacy, Italy
14:50-15:10 Title:- Human Health Under Threat: The Escalation Of Antifungal Resistance
Saloua Kouass Sahbani, 
Taibiah University, Saudi Arabia
15:10-15:30 Title:-Cactus Cladode Extract inhibit DNA base damage induced by gamma radiation
Sylvain Chemtob, 
Université de Montréal, Canada
15:30-15:50 Title:-Efficacy of combined anti-IL-1/IL-6 rytvela+HSJ633 in prevention of prematurity and in preservation of fetal/neonatal lung and gut
Alan L. Peterson, 
University of Texas at San Antonio, USA
15:50-16:10 Title:-Tailored strategies to increase treatment efficacy by combining pharmacotherapies with evidence-based psychotherapies for posttraumatic stress disorder
Richa Seth, 
CSIR, India
16:10-16:30 Title:-From phytochemical to nanomedicine: Enhancing escin stability, cellular uptake, and anticancer efficacy through nanoformulation
Henry Ponce-Rodríguez 
UNAH, Honduras
16:30-16:50 Title:-Quantitative determination of capsaicinoids in varieties of Capsicum chinense and evaluation of their insecticidal activity against Megalurothrips usitatus under laboratory conditions
 Sheila Mathias                              
Virpax Pharma, USA
16:50-17:10 Title:- Why Teams should start the discussion on inclusion and diversity in early phase clinical trial
    Amosy E. M'Koma,                       
Meharry Medical College, USA
17:10-17:30 Title:-New Diagnostic bioassays promote secure Ileal pouch anal anastomosis for indeterminate colitis
Neil Bhowmick,                              
Kairos Pharma, USA
17:30-17:50 Title:-Targeting CD105 Addresses Tumor Dormancy, Sensitizing EGFR-Driven Lung Cancer to Osimertinib
      Stéphanie Andrade,             
University of Porto, Portugal
17:50-18:10 Title:-Breaking through the blood-brain barrier: targeted nanomedicine for Alzheimer's disease
     Maria Jose De Rosa,                 
INIBIBB Argentina
18:10-18:30 Title:- Using C. elegans as a Model System to Identify Antioxidant Therapeutics for Neurodegenerative Diseases
Pietro Gazzola & Parati, 
Italian
Society of Hospital Pharmacy, Italy
18:10-18:30 Title:-Progress and challenges in obesity pharmacotherapy: semaglutide as a milestone
Fatma Karip, 
Gazi University, Turkey
18:10-18:30 Title:-Optimization and Characterization of Tranexamic Acid-Loaded Flexible Liposomes
Panel Discussions
NOTE: This is Tentative program and subject to change
If any one interested to attend the conference or to book your virtual speaker slot, please send an email to: Brian.mitchell@pharmanext.org

Download